Anesthesia Kit Correction: Becton Dickinson Issues Correction for BD Spinal Trays Containing Bupivacaine Ampules
Becton Dickinson (BD) issued a correction for specific Spinal Trays involving the removal of Bupivacaine ampule components from the affected kits.
Healthcare facilities using BD Spinal Trays, surgical staff, and departments responsible for anesthesia kit procurement and safety management.
The removal of a primary drug component from a specialized medical device tray suggests a potential quality or safety issue specifically associated with the Bupivacaine ampules within those kits. Regulatory and clinical teams may need to evaluate the impact on surgical workflows and ensure that subsequent anesthetic sourcing maintains the required standards for spinal procedures. The source does not specify the underlying cause (e.g., potency, contamination, or packaging integrity) of the correction.
QA and supply chain teams should immediately identify and sequester affected BD Spinal Trays in inventory. Clinical staff must be notified regarding the removal of the Bupivacaine ampule component to ensure alternative anesthetic supplies are available during procedures.
BD is correcting affected Spinal Trays by removing Bupivacaine ampule components
Open in openFDA / FDA.gov